All posts
-
AGIBOT organise « AGIBOT NIGHT », un spectacle de gala en direct animé par des robots
Démonstration de la robotique humanoïde fonctionnant à l’échelle dans un environnement culturel vivant , /PRNewswire/ — AGIBOT, une société de robotique de premier belief spécialisée dans l’intelligence incarnée, a organisé aujourd’hui l’AGIBOT NIGHT, un spectacle de gala animé par des robots et diffusé le 8 février. Ce programme de 60 minutes est le premier événement
-
Global Industry Turns Out for Innovation at ISE 2026
ISE 2026, occurring in Barcelona, highlights the most up to date modern technology services in home automation, audio-video, and the relevant modern technology market. The occasion…
-
Schneider Electric Collaborates with the Trilight for Smart Home Solutions
Schneider Electric, a worldwide leader in electronic improvement of power monitoring and automation, has actually teamed up with The Trilight, a high-end domestic team recognized f…
-
Stealth Acoustics at ISE 2026: See Nothing. Hear Everything.
Stealth Acoustics, the sector leader in unnoticeable audio speaker modern technology, will certainly bring the most recent and most sophisticated generation of its unnoticeable aud…
-
Lundbeck CEO on crucial price negotiations for blockbuster drug in the US: “We are prepared”
Lundbeck’s most significant item is dealing with even more competitors and raised cost stress in the United States. According to the firm’s chief executive officer, Lun…
-
Ambu CEO confident in growth targets despite tough conditions from tariffs and FX
The clinical modern technology business remains to be born down by tolls and money headwinds from the United States, which the chief executive officer anticipates to be able to tak…
-
Novo Nordisk CEO on new price pressure risk: We have economies of scale
With substantial cost decreases, Novo Nordisk wishes to recover a few of the clients shed to compounders.
-
GN’s hearing aid activities achieved organic growth of 5% in 2025
In 2026, GN anticipates its listening devices tasks to add natural development of in between 3 and 7%.
-
Lundbeck CEO predicts results for migraine candidate as next major catalyst
Lundbeck’s chief executive officer Charl van Zyl is especially hopeful in the short-term regarding the outcomes of a migraine prospect that Lundbeck is examining in a stage I…
